Merck & Co's Viralytics Buy Puts Oncolytic Viruses Back In Spotlight

 
• By Kevin Grogan
  
Merry-go-round
All aboard: Merck & Co is the latest big pharma to take part in M&A this year • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer